Electrical Storm and Incessant VentricularTachycardia¶
Chapter 263 | Part 6: Disorders of the Cardiovascular System · Part 6 – Cardiovascular Disorders · Chapter 263
Key Clinical Points¶
- Electrical storm is defined as ≥3 episodes of ventricular tachycardia (VT) or ventricular fibrillation (VF) within 24 hours requiring intervention for termination.
- Incessant VT occurs when VT continues to recur shortly after electrical, pharmacologic, or spontaneous conversion to sinus rhythm.
- Prevalence: 4% in patients with primary prevention implantable cardioverter-defibrillator (ICD); up to 20% in those with known VT or resuscitated sudden death.
- Antitachycardia pacing (ATP) effectively terminates >70% of VT episodes, even when VT is very rapid; it is critical for reducing shocks.
- ICD programming: Setting VF detection zones to >220 beats/min significantly reduces inappropriate shocks in primary prevention ICDs.
- Amiodarone combined with beta blockers is more effective than sotalol or beta blockers alone for controlling VT/VF episodes.
- Multiple ICD shocks constitute a medical emergency; patients must never drive themselves to the hospital after receiving an ICD shock.
- Stellate ganglion block (SGB) and upper thoracic epidural anesthesia may reduce cardiac sympathetic outflow and restore stability.
- Catheter ablation is effective for monomorphic VT and PVC-initiated polymorphic VT/VF.
- In myocardial ischemia, emergent revascularization should be attempted to address potentially triggered automaticity in surviving Purkinje cells.
1. DEFINITION & OVERVIEW¶
• Electrical Storm: Defined as the occurrence of ≥3 episodes of ventricular tachycardia (VT) or ventricular fibrillation (VF) within 24 hours requiring intervention for termination. • Incessant Ventricular Tachycardia: - Definition: VT is designated incessant when it continues to recur shortly after electrical, pharmacologic, or spontaneous conversion to sinus rhythm. - Characteristics: Typically monomorphic. It may be missed by an ICD if the tachycardia is slow and falls outside programmed detection parameters. - Causes: May become incessant due to the proarrhythmic effect of drugs such as amiodarone or sodium channel blockers like flecainide.
2. EPIDEMIOLOGY¶
• Prevalence: - 4% of patients with a primary prevention implantable cardioverter-defibrillator (ICD). - Up to 20% of patients with a history of known VT or resuscitated sudden death. • Clinical Risk: Spontaneous arrhythmias, particularly those requiring shock conversion, are associated with an increased risk of death and hospitalization in patients with depressed ventricular function.
3. ETIOLOGY & PATHOPHYYSICS¶
• Proarrhythmic Drug Effects: - Amiodarone - Sodium channel blockers (e.g., flecainide) • Clinical Indicators of Deterioration: The occurrence of an arrhythmia warrants immediate reevaluation for: - Decline in cardiac function - Emergence of ischemia - Intercurrent illness
4. CLINICAL FEATURES¶
• General Presentation: Can signal impending instability, deterioration of cardiac function, or the emergence of a new arrhythmia. • Hemodynamic Stability: - If stable acutely, patients may present with symptoms of gradual cardiac decompensation. • Post-Shock Considerations: - Risk of death and hospitalization in patients with depressed ventricular function. - Impact on quality of life; potential for posttraumatic stress disorder (PTSD).
5. DIFFERENTIAL DIAGNOSIS¶
• Stable vs. Unstable: - A rare episode of VT that is appropriately terminated by antitachycardia pacing (ATP) without other evidence of instability may not require additional therapy. - Recurrent symptomatic episodes of VT or VF warrant specific therapy with antiarrhythmic drugs or catheter ablation.
6. INVESTIGATIONS & DIAGNOSIS¶
- ICD Interrogation:
- Must be performed after a patient reports a shock or symptoms of arrhythmia.
- Purpose: Confirm therapy was for VT/VF and not due to lead malfunction or other arrhythmias.
- ECG Monitoring:
- Used to assess whether VT terminates spontaneously or requires intervention.
- Emergency Protocol:
- Medical Emergency: Occurrence of multiple ICD shocks constitutes a medical emergency; activate the emergency medical system immediately.
- Patient Safety: Patients must never drive themselves to the hospital after receiving an ICD shock.
7. MANAGEMENT & TREATMENT¶
- General Stabilization:
- Follow standard Advanced Cardiac Life Support (ACLS) guidelines.
- Medications: Beta blockers, amiodarone, and lidocaine; correct metabolic abnormalities.
- Supportive care: Adequate sedation to allay anxiety and provide pain relief.
- ICD Programming:
- Antitachycardia Pacing (ATP): Effectively terminates >70% of VT episodes, even when very rapid.
- Optimization: Program ICDs to attempt overdrive pacing during capacitor charge to abort the shock.
- Prevention: For primary prevention, set VF detection zones to >220 beats/min to reduce inappropriate shocks; use long detection times to avoid therapy for self-terminating VT.
- Global Strategy (Table 1):
- Stabilize rhythm: Defibrillation, Amiodarone, Lidocaine, Revascularization, Catheter ablation.
- Relieve triggers: Electrolyte management, Volume removal, Quinidine, Ranolazine, Procainamide.
- Reduce sympathetic drive: Beta blockers, Sedation and intubation, Anxiolytics, Overdrive pacing, Mechanical support (ECMO/IABP), Stellate ganglion block (SGB).
- Management Algorithm for Electrical Storm (Flowchart): Identify Morphology → Determine Management Path:
- Monomorphic VT (MMVT): Beta blockade, Amiodarone, Lidocaine, Sedation, ECM1, SGB, Catheter ablation.
- Polymorphic VT/VF (PMVT/VF) → Identify Subtype:
- Long QT: Electrolyte repletion, Magnesium, Pacing, Isoproterenol, Lidocaine, SGB.
- Normal QT / ischemic: Beta blockade, Amiodarone, Lidocaine, IABP, Revascularization.
- PVC-initiated: Beta blockade, Amiodarone, Lidocaine, SGB, Sedation, Catheter ablation.
- Brugada: Quinidine, Non-DHP CCB, Isoproterenol, Catheter ablation.
- Inflammatory: Steroid pulse, Amiodarone, SGB.
Management of Specific Subtypes¶
• Myocardial Ischemia: - If polymorphic VT/VF is the primary arrhythmia, consider ischemia. - Acute coronary syndrome → Emergent revascularization and alleviation of anginal symptoms. - Note: Surviving Purkinje cells in infarcted tissue may exhibit triggered automaticity. • PVC-initiated Polymorphic VT/VF: - Often caused by triggering from fascicular tissue or papillary muscles. - Identified on cardiac MRI as scarred myocardial tissue. - Catheter ablation indicated if antiarrhythmic medication is ineffective. • Acquired or Congenital Long QT Syndrome: - Torsades de pointes (TdP) risk → IV Magnesium for immediate effect on repolarization. - Aggressive electrolyte repletion (especially potassium). - Increase heart rate via pharmacologic or pacing support. - Isoproterenol: Increases sinus rate; caution as high doses may increase ectopy. • Brugada Syndrome: - Management: Beta blockade, Quinidine, Non-DHP CCB, Stellate ganglion block (SGB), Catheter ablation. • Inflammatory Conditions: - Management: Steroid pulse, SGB, Catheter ablation. • Mechanical Support: - Options: ECMO, percutaneous LVAD, or IABP. • Stellate Ganglion Block (SGB): - Percutaneous SGB and upper thoracic epidural anesthesia may reduce cardiac sympathetic outflow to restore stability.
8. PROGNOSIS & COMPLICATIONS¶
• Clinical Outcomes: Spontaneous arrhythmias, especially those requiring shock, are associated with increased risk of death and hospitalization in patients with depressed ventricular function. • Quality of Life: Frequent shocks can lead to posttraumatic stress disorder (PTSD).
9. KEY PEARLS & CLINICAL TRAPS¶
• Emergency Rule: Patients must never drive themselves after an ICD shock; multiple shocks are a medical emergency requiring immediate EMS activation. • Intervention Trade-offs: While interventions control the arrhythmia, they may have adverse effects on outcome (e.g., antiarrhythmic drugs causing bradycardia → potentially deleterious effect on ventricular function). • Programming Importance: Proper ICD programming is critical to reduce shocks and improve quality of life.